News
AIM ImmunoTech Inc. (NYSE American: AIM) (the "Company"), today announced the pricing of a public offering of an aggregate of 2,000,000 shares of its common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback